Aug 16, 2017 12:00:00 AM US PromarkerD patent expanded to all kidney disease Proteomics Share: facebook-f icon linkedin-in icon Twitter icon pinterest-p icon envelope icon Proteomics International is pleased to announce that the United States patent for its PromarkerD diagnostic test has been expanded to include all kidney disease. Media release 2017
